Chambers AF - Search Results

1

O6-methylguanine-DNA methyltransferase in tumors and cells of the oligodendrocyte lineage.

Nutt CL, Costello JF, Bambrick LL, Yarosh DB, Swinnen LJ, Chambers AF, Cairncross JG. Nutt CL, et al. Among authors: chambers af. Can J Neurol Sci. 1995 May;22(2):111-5. doi: 10.1017/s0317167100040178. Can J Neurol Sci. 1995. PMID: 7627911

2

Wild-type p53 renders mouse astrocytes resistant to 1,3-Bis(2-chloroethyl)-1-nitrosourea despite the absence of a p53-dependent cell cycle arrest [corrected].

Nutt CL, Chambers AF, Cairncross JG. Nutt CL, et al. Among authors: chambers af. Cancer Res. 1996 Jun 15;56(12):2748-51. Cancer Res. 1996. PMID: 8665508

3

O(6)-methylguanine-DNA methyltransferase activity, p53 gene status and BCNU resistance in mouse astrocytes.

Nutt CL, Loktionova NA, Pegg AE, Chambers AF, Cairncross JG. Nutt CL, et al. Among authors: chambers af. Carcinogenesis. 1999 Dec;20(12):2361-5. doi: 10.1093/carcin/20.12.2361. Carcinogenesis. 1999. PMID: 10590234

4

Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy.

Nutt CL, Noble M, Chambers AF, Cairncross JG. Nutt CL, et al. Among authors: chambers af. Cancer Res. 2000 Sep 1;60(17):4812-8. Cancer Res. 2000. PMID: 10987291

5

Malignant properties of P635 glioma are independent of glial fibrillary acidic protein expression.

Chambers AF, Denhardt GH, Wilson SM, Cairncross JG. Chambers AF, et al. J Neurooncol. 1991 Aug;11(1):43-8. doi: 10.1007/BF00166996. J Neurooncol. 1991. PMID: 1919645

6

Comparison of metastatic properties of a variety of mouse, rat, and human cells in assays in nude mice and chick embryos.

Chambers AF, Wilson SM, Tuck AB, Denhardt GH, Cairncross JG. Chambers AF, et al. In Vivo. 1990 Jul-Aug;4(4):215-9. In Vivo. 1990. PMID: 2103362

7

p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression.

van Meyel DJ, Ramsay DA, Casson AG, Keeney M, Chambers AF, Cairncross JG. van Meyel DJ, et al. Among authors: chambers af. J Natl Cancer Inst. 1994 Jul 6;86(13):1011-7. doi: 10.1093/jnci/86.13.1011. J Natl Cancer Inst. 1994. PMID: 8007011

8

Absence of hereditary mutations in exons 5 through 9 of the p53 gene and exon 24 of the neurofibromin gene in families with glioma.

van Meyel DJ, Ramsay DA, Chambers AF, Macdonald DR, Cairncross JG. van Meyel DJ, et al. Among authors: chambers af. Ann Neurol. 1994 Jan;35(1):120-2. doi: 10.1002/ana.410350120. Ann Neurol. 1994. PMID: 8285583

9

Genetic background influences timing, morphology and dissemination of lymphomas in p53-deficient mice.

van Meyel DJ, Sanchez-Sweatman OH, Kerkvliet N, Stitt L, Ramsay DA, Khokha R, Chambers AF, Cairncross JG. van Meyel DJ, et al. Among authors: chambers af. Int J Oncol. 1998 Nov;13(5):917-22. doi: 10.3892/ijo.13.5.917. Int J Oncol. 1998. PMID: 9772279

10

Osteopontin expression in lung cancer.

Chambers AF, Wilson SM, Kerkvliet N, O'Malley FP, Harris JF, Casson AG. Chambers AF, et al. Lung Cancer. 1996 Nov;15(3):311-23. doi: 10.1016/0169-5002(95)00595-1. Lung Cancer. 1996. PMID: 8959677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters